<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-109188</identifier>
<setSpec>1134-3230</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Reply to Relimpio et al: As regards the Special Issue on insulin aspart</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>Escalada, Javier</dc:creator>
<dc:creator>Conget, Ignacio</dc:creator>
<dc:creator>Giménez, Marga</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Av. diabetol;28(5): 121-122, sept.-oct. 2012.</dc:source>
<dc:identifier>ibc-109188</dc:identifier>
<dc:title xml:lang="es">Respuesta a Relimpio et al: En relación con el número extraordinario monográfico sobre insulina aspártica</dc:title>
<dc:subject>^d3942^s22080</dc:subject>
<dc:subject>^d54564^s22073</dc:subject>
<dc:subject>^d29625</dc:subject>
<dc:subject>^d37728</dc:subject>
<dc:subject>^d11671^s22080</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d54564^s22000</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3942^s22054</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d11671^s22054</dc:subject>
<dc:type>article</dc:type>
<dc:date>201210</dc:date>
</metadata>
</record>
</ibecs-document>
